| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 0.46 | 0.90 | 32.51 | 6.07 |
| Receivables | 1.69 | 4.26 | 1.57 | 8.07 |
| Inventory | 20.53 | 14.22 | — | — |
| Other | 7.08 | 4.40 | 2.00 | 1.31 |
| 29.77 | 23.77 | 36.09 | 15.44 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 12.10 | 9.79 | 5.41 | 6.01 |
| ST’ Debt | — | — | — | — |
| Other | 2.78 | 2.66 | — | — |
| 26.09 | 22.27 | 7.21 | 6.54 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.45 | 0.39 | — | — |
—
|
| ’25 | 1.47 | 0.79 | 0.74 | 1.36 |
4.36
|
| ’24 | 4.93 | 2.65 | 4.04 | 1.66 |
13.28
|
| ’23 | 23.96 | 19.63 | 11.80 | 9.99 |
65.37
|
| ’22 | 46.53 | 39.92 | 28.68 | 21.96 |
137.09
|
| ’21 | 34.01 | 34.72 | 41.31 | 56.02 |
166.06
|
| ’20 | 33.87 | 32.40 | 35.76 | 36.27 |
138.30
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (4.83) | (2.27) | — | — |
—
|
| ’25 | (3.44) | (4.45) | (3.91) | (4.46) |
(16.26)
|
| ’24 | (0.08) | (0.30) | (4.85) | (1.52) |
(6.75)
|
| ’23 | 1.88 | 2.77 | (3.46) | (2.98) |
(1.79)
|
| ’22 | (12.02) | (1.71) | (8.76) | (3.94) |
(26.43)
|
| ’21 | (15.26) | 0.10 | (16.87) | (5.30) |
(37.33)
|
| ’20 | (1.10) | (1.32) | (1.34) | (8.55) |
(12.30)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (14.96) | (3.43) | — | — |
—
|
| ’25 | (3.46) | (4.50) | (3.91) | (12.64) |
(24.52)
|
| ’24 | (0.22) | (0.31) | (4.87) | (1.59) |
(6.99)
|
| ’23 | 1.71 | 2.64 | (3.79) | (3.36) |
(2.80)
|
| ’22 | (12.73) | (2.19) | 0.37 | (5.06) |
(19.62)
|
| ’21 | (15.68) | (0.67) | (17.65) | (7.37) |
(41.37)
|
| ’20 | (2.09) | (1.57) | (1.83) | (9.11) |
(14.60)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (4.49) | (6.06) | — | — |
—
|
| ’25 | (1.97k) | (25.44) | (51.52) | — |
(91.36)
|
| ’24 | (57.54k) | (8.18k) | (14.03k) | — |
(89.60k)
|
| ’23 | (433.27k) | (444.11k) | (129.31k) | — |
(552.42k)
|
| ’22 | (2.30m) | (1.54m) | (7.74m) | (690.53k) |
(10.41m)
|
| ’21 | (3.79m) | (2.17m) | (5.55m) | (1.22m) |
(10.70m)
|
| ’20 | (5.82m) | (2.44m) | (4.74m) | (3.52m) |
(16.52m)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 178,200.00 | 30,888.00 | 8,400.00 | 12.00 | — | — | — |
Low Price
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13,860,000.00 | 385,440.00 | 130,800.00 | 10,740.00 | — | — | — |
High Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 145 | 66 | 49 | 11 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.95 | 0.99 | 0.27 | 0.40 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 137.09 | 65.37 | 13.28 | 4.36 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.22% | 27.27% | 47.32% | (286.22%) | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (182.24) | (32.32) | (17.66) | (85.57) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (132.94%) | (49.45%) | (133.01%) | (1,964.94%) | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (182.23) | (32.32) | (17.66) | (85.58) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 79.41 | 5.06 | 5.73 | 0.78 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 108,955.00 | 87.62 | 4.65 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (10,405,350.00) | (552,424.50) | (89,600.00) | (91.36) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | (2,988.33) | (44.55) | (17.36) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | (1,678.33) | (1.61) | (8.82) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | (4,666.67) | (46.16) | (26.19) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 18,320.00 | 41.47 | 72.32 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 0.15 | 0.94 | — | — | — |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.30 | 112.98 | 2.70 | — | — | — |
PS Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 1.79 | 238.75 | 0.17 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.04 | 0.39 | 113.37 | (3.37) | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.29) | (9.01) | (215.19) | 0.60 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (26.43) | (1.79) | (6.75) | (16.26) | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.81 | (1.01) | (0.24) | (8.26) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (19.62) | (2.80) | (6.99) | (24.52) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.04 | 3.68 | 1.51 | 28.88 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.91 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.73 | (0.46) | (0.90) | (32.51) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.99 | 10.99 | 6.28 | 67.72 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (90.28%) | (50.36%) | (52.87%) | (165.27%) | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (257.27%) | (154.83%) | (137.18%) | (96.29%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (144.05%) | (128.74%) | (204.24%) | (231.28%) | — | — | — |
ROE
|
Greenlane Holdings (GNLN), a leading distributor of cannabis accessories and vaping products, rode the U.S. cannabis boom post-2018 Farm Bill to peak revenues of $185 million in 2019, only to suffer an 80% plunge to $13.3 million in 2024 amid vape crises, flavor bans, the PACT Act, COVID disruptions, and macroeconomic squeezes. Employee headcount halved repeatedly alongside sales, yet revenue per employee highlighted cost discipline before recent efficiency dips, while gross margins soared 291% to 47.3% through inventory shifts and pricing power—though persistent losses exceeding $350 million since 2018, negative ROA/ROE, and high interest rates underscore ongoing balance sheet strain.
Despite the revenue cliff, GNLN’s balance sheet shows resilience with reduced debt, a net cash position, and rock-bottom valuations (PS ratio at 0.15, PB at 0.32), trading at depressed levels post-SPAC hype and reverse splits. Analyst price targets imply astronomical upside—up to 18 million%—betting on federal rescheduling to Schedule III, potential M&A, or macro relief like rate cuts, positioning it as a high-beta speculative play amid sector maturation pains, regulatory fog, and competitive threats. Read the full analysis for deeper dives into fundamentals and risks.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.